These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8435843)
1. [Mechanisms of the effect of antiviral agents]. Holý A Cas Lek Cesk; 1993 Jan; 132(1):12-7. PubMed ID: 8435843 [TBL] [Abstract][Full Text] [Related]
2. L-nucleoside enantiomers as antivirals drugs: a mini-review. Mathé C; Gosselin G Antiviral Res; 2006 Sep; 71(2-3):276-81. PubMed ID: 16797735 [TBL] [Abstract][Full Text] [Related]
4. [The emergence of viruses resistant to antiviral agents: a new challenge]. Boivin G Union Med Can; 1993; 122(1):31-6. PubMed ID: 8465473 [TBL] [Abstract][Full Text] [Related]
5. Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species. Prado-Prado FJ; Borges F; Uriarte E; Peréz-Montoto LG; González-Díaz H Anal Chim Acta; 2009 Oct; 651(2):159-64. PubMed ID: 19782806 [TBL] [Abstract][Full Text] [Related]
6. Protein-protein interactions as targets for antiviral chemotherapy. Loregian A; Marsden HS; Palù G Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015 [TBL] [Abstract][Full Text] [Related]
7. 3'-Fluoro-3'-deoxy-5'-noraristeromycin derivatives: synthesis and antiviral analysis. Roy A; Serbessa T; Schneller SW Bioorg Med Chem; 2006 Jul; 14(14):4980-6. PubMed ID: 16581253 [TBL] [Abstract][Full Text] [Related]
9. [Nonspecific antiviral preparations: hopes and realities (a review of the literature)]. Markin VA Voen Med Zh; 2000 Aug; 321(8):51-60, 96. PubMed ID: 10998996 [TBL] [Abstract][Full Text] [Related]
10. [Antiviral properties of microbial polysaccharides--a review]. Kovalenko AG Zentralbl Mikrobiol; 1987; 142(4):301-10. PubMed ID: 3116778 [TBL] [Abstract][Full Text] [Related]
11. [Multiplication of viruses. I. Chemical inhibitors and the problem of antiviral chemotherapy]. Werner GH Nouv Presse Med; 1972 Mar; 1(12):805-8. PubMed ID: 5015458 [No Abstract] [Full Text] [Related]
12. [Reviews on antiviral activity of chemical constituents from plants]. Yang XF; Wang YL; Xu WR Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):100-4. PubMed ID: 18338629 [TBL] [Abstract][Full Text] [Related]
15. [Antiviral agents that act in the early phases of the viral cycle]. Damonte EB Rev Argent Microbiol; 1996; 28(4):204-16. PubMed ID: 9102661 [TBL] [Abstract][Full Text] [Related]
16. Rational design of polymerase inhibitors as antiviral drugs. Oberg B Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225 [TBL] [Abstract][Full Text] [Related]
17. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases. Nijhuis M; van Maarseveen NM; Boucher CA Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205 [TBL] [Abstract][Full Text] [Related]
18. Antivirals against DNA viruses (hepatitis B and the herpes viruses). Hewlett G; Hallenberger S; Rübsamen-Waigmann H Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349 [TBL] [Abstract][Full Text] [Related]